4//SEC Filing
Bhatia Sangeeta N. 4
Accession 0000875320-25-000222
CIK 0000875320other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:02 PM ET
Size
4.7 KB
Accession
0000875320-25-000222
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Sale
Common Stock
2025-08-27$386.69/sh−266$102,860→ 4,565 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001643921
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:02 PM ET
- Size
- 4.7 KB